Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc. financial statements

Cellectar Biosciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 21.79M10-K
Cash and equivalentsUSD 13.2M10-Q
Total debtUSD 409.59KEODHD

Cellectar Biosciences, Inc. financials on 6ix · Cellectar Biosciences, Inc. on 6ix